LLY

712.3

-0.96%↓

JNJ

152.93

+0.1%↑

ABBV

183.65

+0.55%↑

NVO

66.97

-1.89%↓

UNH

293.62

-2.2%↓

LLY

712.3

-0.96%↓

JNJ

152.93

+0.1%↑

ABBV

183.65

+0.55%↑

NVO

66.97

-1.89%↓

UNH

293.62

-2.2%↓

LLY

712.3

-0.96%↓

JNJ

152.93

+0.1%↑

ABBV

183.65

+0.55%↑

NVO

66.97

-1.89%↓

UNH

293.62

-2.2%↓

LLY

712.3

-0.96%↓

JNJ

152.93

+0.1%↑

ABBV

183.65

+0.55%↑

NVO

66.97

-1.89%↓

UNH

293.62

-2.2%↓

LLY

712.3

-0.96%↓

JNJ

152.93

+0.1%↑

ABBV

183.65

+0.55%↑

NVO

66.97

-1.89%↓

UNH

293.62

-2.2%↓

Search

Minerva Neurosciences Inc

Open

1.42 1.43

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

1.36

Max

1.5

Belangrijke statistieken

By Trading Economics

K/W

Sectorgemiddelde

7

54.533

Werknemers

8

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+244.83% upside

Dividenden

By Dow Jones

Volgende Winsten

5 aug 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-4.6M

8.3M

Vorige openingsprijs

-0.01

Vorige sluitingsprijs

1.42

Minerva Neurosciences Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 mei 2025, 23:48 UTC

Populaire aandelen

Stocks to Watch: Deckers Outdoor, Intuit, Ross Stores, Lightbridge, NuScale Power, Centrus Energy

22 mei 2025, 23:07 UTC

Top Nieuws

Fortescue Energy CEO to Resign in Executive Overhaul

22 mei 2025, 23:03 UTC

Belangrijke Marktbewegers

Nuclear-Industry Stocks Get Boost After Report Says Trump Will Sign Orders to Jumpstart Field

22 mei 2025, 23:59 UTC

Marktinformatie

Gold Edges Higher, Supported by Lingering Worries Over U.S. Deficits -- Market Talk

22 mei 2025, 23:45 UTC

Marktinformatie

Nikkei May Trade in Range as Uncertainty Over Tariffs Continues -- Market Talk

22 mei 2025, 23:45 UTC

Marktinformatie

Global Equities Roundup: Market Talk

22 mei 2025, 23:23 UTC

Marktinformatie

Global Energy Roundup: Market Talk

22 mei 2025, 23:23 UTC

Marktinformatie

Fortescue Iron Bridge Delay Disappoints; Executive Changes Welcomed -- Market Talk

22 mei 2025, 23:12 UTC

Top Nieuws

Supreme Court Lets Trump Fire Agency Officials, but Moves to Protect Fed -- WSJ

22 mei 2025, 21:54 UTC

Top Nieuws

Global Finance Officials Gloss Over Trade Tensions At G-7 Summit -- WSJ

22 mei 2025, 20:50 UTC

Marktinformatie

Auto & Transport Roundup: Market Talk

22 mei 2025, 20:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

22 mei 2025, 20:46 UTC

Acquisities, Fusies, Overnames

Alcon and Lensar Receive FTC Requests for Additional Information About Merger

22 mei 2025, 20:39 UTC

Winsten

Tesla's Emissions Credits Are at Risk After Senate's California Vote -- Barrons.com

22 mei 2025, 20:36 UTC

Top Nieuws

Antitrust Cops Say BlackRock, Other Fund Giants May Have Harmed Energy Competition -- 4th Update

22 mei 2025, 20:36 UTC

Top Nieuws
Winsten

Workday Logs Higher 1Q Revenue, Backs Outlook; Initiates $1B Buyback Program

22 mei 2025, 20:32 UTC

Top Nieuws
Winsten

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22 mei 2025, 20:27 UTC

Top Nieuws

Trump's 'Big, Beautiful Bill' Heads to Senate, Where New Fights Loom -- WSJ

22 mei 2025, 20:20 UTC

Top Nieuws

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22 mei 2025, 20:17 UTC

Top Nieuws

The Deficit Is Unsettling Bond Traders. Here's How That Affects the Economy. -- 2nd Update

22 mei 2025, 20:16 UTC

Winsten

Intchains Group 1Q Rev $18.2M >ICG

22 mei 2025, 20:15 UTC

Top Nieuws

Bond Market Shows Signs of Stabilizing; Nasdaq Rises -- WSJ

22 mei 2025, 20:08 UTC

Top Nieuws
Winsten

Intuit Stock Rises After Earnings Grew More than Expected In Latest Tax Season -- Barrons.com

22 mei 2025, 20:05 UTC

Top Nieuws

Intuit Seeing Stable Environment for Consumers, Businesses While Tariffs Play Out

22 mei 2025, 20:04 UTC

Winsten

Workday Sees FY26 Subscription Revenue $8.8B >WDAY

22 mei 2025, 20:04 UTC

Winsten

Workday Sees 2Q Subscription Revenue $2.16B >WDAY

22 mei 2025, 20:01 UTC

Winsten

Intuit Sees FY25 EPS $13.19-EPS $12.24 >INTU

22 mei 2025, 20:01 UTC

Winsten

Workday 1Q Net $68M >WDAY

22 mei 2025, 20:01 UTC

Winsten

Workday 1Q EPS 25c >WDAY

22 mei 2025, 20:01 UTC

Winsten

Workday 1Q Adj EPS $2.23 >WDAY

Peer Vergelijking

Prijswijziging

Minerva Neurosciences Inc Prognose

Koersdoel

By TipRanks

244.83% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 5 USD  244.83%

Hoogste 5 USD

Laagste 5 USD

Gebaseerd op 1 Wall Street-analisten die 12-maands prijsdoelen bieden voor Minerva Neurosciences Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

1 ratings

0

Buy

1

Hold

0

Sell

Financieel

$

Over Minerva Neurosciences Inc

Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.